1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow DiGeorge Anomaly: new trials by email Literature Review of DiGeorge Anomaly trials Research Report on DiGeorge Anomaly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thymus Transplantation Safety-Efficacy Cultured Thymus Tissue - Complete DiGeorge Anomaly, DiGeorge Syndrome | Not applicable | Completed | Sumitomo Pharma Switzerland GmbH | 29 | 2010-12-01 | 2025-01-16 |
DiGeorge Syndrome (1) · Immunologic Deficiency Syndromes (1) · Thymic aplasia (1)
22q11 Deletion Syndrome (1) · Abnormalities, Multiple (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypoparathyroidism (1) · Immune System Diseases (1)
Sumitomo Pharma Switzerland GmbH (1)
United States (1)
K12HD043494 (1), R01AI047040 (1)